Personal information

Verified email domains

Activities

Funding (9)

Enabling enhanced preclinical nuclear imaging at the University of Hull

2022-10-31 to 2023-03-30 | Grant
Medical Research Council (London, GB)
GRANT_NUMBER: MR/X013774/1
Source: Self-asserted source
Michael Lind via DimensionsWizard

Adapting a smartphone-based rehabilitation programme for older adults living with and beyond cancer: a development study using Intervention Mapping

2022-04-01 to 2024-04-30 | Grant
National Institute for Health and Care Research (London, GB)
GRANT_NUMBER: NIHR203123
Source: Self-asserted source
Michael Lind via DimensionsWizard

CANcer BEhavioural nutrition and exercise feasibility trial (CanBenefit) among older adults with lung cancer

2021-09-01 to 2023-06-30 | Grant
Yorkshire Cancer Research (Harrogate, GB)
GRANT_NUMBER:

HEND405CANB

Source: Self-asserted source
Michael Lind via DimensionsWizard

Reducing Inequalities in Cancer Outcomes in Yorkshire: Realising our potential for innovation in Diagnosis, Patient Management, Survivorship and Palliative Care Research

2017-09-01 to 2022-08-31 | Grant
Yorkshire Cancer Research (Harrogate, GB)
GRANT_NUMBER:

grant.6848638

Source: Self-asserted source
Michael Lind via DimensionsWizard

Peripheral Blood detection of EGFR status in lung cancer patients

2016-03-01 to 2017-08-31 | Grant
Yorkshire Cancer Research (Harrogate, GB)
GRANT_NUMBER:

grant.6848664

Source: Self-asserted source
Michael Lind via DimensionsWizard

Yorkshire Cancer Research Centre for Early Phase Clinical Trials

2014-06-01 to 2019-07-31 | Grant
Yorkshire Cancer Research (Harrogate, GB)
GRANT_NUMBER:

grant.6848645

Source: Self-asserted source
Michael Lind via DimensionsWizard

The Yorkshire Cancer Research Centre for Early Phase Clinical Trials

2013-01-01 to 2019-12-31 | Grant
Yorkshire Cancer Research (Harrogate, GB)
GRANT_NUMBER:

grant.6848644

Source: Self-asserted source
Michael Lind via DimensionsWizard

Point-of-care blood device for fast and reliable prediction of drug response in non-small cell lung carcinoma patients from blood samples (LungCARD 315586). €1 million

2013 to 2015 | Grant
European Commission (Brussels, BE)
Source: Self-asserted source
Michael Lind

Development of a microfluidic device for response to chemotherapy in malignant mesothelioma. £24,800; 2013-2015

Grant
British Lung Foundation (London, GB)
Source: Self-asserted source
Michael Lind

Peer review (1 review for 1 publication/grant)

Review activity for PloS one. (1)